Frequency of the common promoter polymorphism MMP2 −1306 C>T in a population from central Bulgaria

References

• Nagase H, Woessner JF Jr. Matrix metalloproteinases. J Biol Chem. 1999;274:21491–21494.
   PubMed Web of Science ®Google Scholar
• Vlaykova T, Dimov D. Polymorphisms of matrix metalloproteinases (MMP) in COPD. Biotechnol Biotechnol Equip. 2012;26(Suppl. 1):111–119.
   Web of Science ®Google Scholar
• Yadav SS, Mandal RK, Singh MK, Usman K, Khattri S. Genetic variants of matrix metalloproteinase (MMP2) gene influence metabolic syndrome susceptibility. Genet Test Mol Biomarkers. 2014;18:88–92.
   PubMed Web of Science ®Google Scholar
• Mishev G, Deliverska E, Hlushchuk R, Velinov N, Aebersold D, Weinstein F, Djonov V. Prognostic value of matrix metalloproteinases in oral squamous cell carcinoma. Biotechnol Biotechnol Equip. 2014;28(6):1138–1149.
   PubMed Web of Science ®Google Scholar
• Kerkela E, Saarialho-Kere U. Matrix metalloproteinases in tumor progression: focus on basal and squamous cell skin cancer. Exp Dermatol. 2003;12:109–125.
   PubMed Web of Science ®Google Scholar
• Amalinei C, Caruntu ID, Giusca SE, Balan RA. Matrix metalloproteinases involvement in pathologic conditions. Rom J Morphol Embryol. 2010;51:215–228.
   PubMed Web of Science ®Google Scholar
• Anastasov A, Vlaykova T. Matrix metalloproteinases in tumor biology – a special attention on their role in HNSCC. Trakia J Sci. 2011;9:74–81.
   Google Scholar
• Tacheva T, Dimov D, Vlaykova T. Gelatinases in COPD and bronchial asthma. Sci Technol Med. 2012;2(1):255–260.
   Google Scholar
• Basbaum CB, Werb Z. Focalized proteolysis: spatial and temporal regulation of extracellular matrix degradation at the cell surface. Curr Opin Cell Biol. 1996;8:731–738.
   PubMed Web of Science ®Google Scholar
• Clark IM, Swingler TE, Sampieri CL, Edwards DR. The regulation of matrix metalloproteinases and their inhibitors. Int J Biochem Cell Biol. 2008;40:1362–1378.
   PubMed Web of Science ®Google Scholar
• Fanjul-Fernandez M, Folgueras AR, Cabrera S, Lopez-Otin C. Matrix metalloproteinases: evolution, gene regulation and functional analysis in mouse models. Biochim Biophys Acta. 2010;1803:3–19.
   PubMed Web of Science ®Google Scholar
• Vihinen P, Ala-aho R, Kahari VM. Matrix metalloproteinases as therapeutic targets in cancer. Curr Cancer Drug Targets. 2005;5:203–220.
   PubMed Web of Science ®Google Scholar
• O-Charoenrat P, Khantapura P. The role of genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes in head and neck cancer. Oral Oncol. 2006;42:257–267.
   PubMed Web of Science ®Google Scholar
• Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res. 2003;92:827–839.
   PubMed Web of Science ®Google Scholar
• Nagase H, Visse R, Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res. 2006;69:562–573.
   PubMed Web of Science ®Google Scholar
• Vihinen P, Kahari VM. Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets. Int J Cancer. 2002;99:157–166.
   PubMed Web of Science ®Google Scholar
• Ala-aho R, Kahari VM. Collagenases in cancer. Biochimie. 2005;87:273–286.
   PubMed Web of Science ®Google Scholar
• Qin H, Sun Y, Benveniste EN. The transcription factors Sp1, Sp3, and AP-2 are required for constitutive matrix metalloproteinase-2 gene expression in astroglioma cells. J Biol Chem. 1999;274:29130–29137.
   PubMed Web of Science ®Google Scholar
• Xie TX, Wei D, Liu M, Gao AC, Ali-Osman F, Sawaya R, Huang S. Stat3 activation regulates the expression of matrix metalloproteinase-2 and tumor invasion and metastasis. Oncogene. 2004;23:3550–3560.
   PubMed Web of Science ®Google Scholar
• Dai B, Kang SH, Gong W, Liu M, Aldape KD, Sawaya R, Huang S. Aberrant FoxM1B expression increases matrix metalloproteinase-2 transcription and enhances the invasion of glioma cells. Oncogene. 2007;26:6212–6219.
   PubMed Web of Science ®Google Scholar
• Ye S. Polymorphism in matrix metalloproteinase gene promoters: implication in regulation of gene expression and susceptibility of various diseases. Matrix Biol. 2000;19:623–629.
   PubMed Web of Science ®Google Scholar
• Li Y, Sun DL, Duan YN, Zhang XJ, Wang N, Zhou RM, Chen ZF, Wang SJ. Association of functional polymorphisms in MMPs genes with gastric cardia adenocarcinoma and esophageal squamous cell carcinoma in high incidence region of North China. Mol Biol Rep. 2010;37:197–205.
   PubMed Web of Science ®Google Scholar
• Sambrook J, Fritch E, Maniatis T. Molecular cloning, laboratory manual. New York (NY): Cold Spring Harbor Laboratory Press; 1989.
   Google Scholar
• Ortak H, Demir S, Ates O, Sogut E, Alim S, Benli I. Association of MMP2-1306C/T and TIMP2G-418C polymorphisms in retinal vein occlusion. Exp Eye Res. 2013;113:151–155.
   PubMed Web of Science ®Google Scholar
• National Center for Biotechnology Information (NCBI). [Internet] Reference SNP (refSNP) Cluster Report: rs243865. Available from: http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=243865.
   Google Scholar
• Elander N, Soderkvist P, Fransen K. Matrix metalloproteinase (MMP)-1, -2, -3 and -9 promoter polymorphisms in colorectal cancer. Anticancer Res. 2006;26:791–795.
   PubMed Web of Science ®Google Scholar
• Kader AK, Shao L, Dinney CP, Schabath MB, Wang Y, Liu J, Gu J, Grossman HB, Wu X. Matrix metalloproteinase polymorphisms and bladder cancer risk. Cancer Res. 2006;66:11644–11648.
   PubMed Web of Science ®Google Scholar
• van Diemen CC, Postma DS, Siedlinski M, Blokstra A, Smit HA, Boezen HM. Genetic variation in TIMP1 but not MMPs predict excess FEV1 decline in two general population-based cohorts. Respir Res. 2011;12:57.
   PubMed Web of Science ®Google Scholar
• Xu E, Lai M, Lv B, Xing X, Huang Q, Xia X. A single nucleotide polymorphism in the matrix metalloproteinase-2 promoter is associated with colorectal cancer. Biochem Biophys Res Commun. 2004;324:999–1003.
   PubMed Web of Science ®Google Scholar
• Mossbock G, Weger M, Faschinger C, Zimmermann C, Schmut O, Renner W, El-Shabrawi Y. Role of functional single nucleotide polymorphisms of MMP1, MMP2, and MMP9 in open angle glaucomas. Mol Vis. 2010;16:1764–1770.
   PubMed Web of Science ®Google Scholar
• Greenlee KJ, Werb Z, Kheradmand F. Matrix metalloproteinases in lung: multiple, multifarious, and multifaceted. Physiol Rev. 2007;87:69–98.
   PubMed Web of Science ®Google Scholar
• Kim JY, Choeng HC, Ahn C, Cho SH. Early and late changes of MMP-2 and MMP-9 in bleomycin-induced pulmonary fibrosis. Yonsei Med J. 2009;50:68–77.
   PubMed Web of Science ®Google Scholar
• Lu L, Gunja-Smith Z, Woessner JF, Ursell PC, Nissen T, Galardy RE, Xu Y, Zhu P, Schwartz GG. Matrix metalloproteinases and collagen ultrastructure in moderate myocardial ischemia and reperfusion in vivo. Am J Physiol Heart Circ Physiol. 2000;279:H601–H609.
   PubMed Web of Science ®Google Scholar
• Vlaykova T, Dimov D, Kurzawski M, Wajda A, Lapczuk J, Anastasov A, Drozdzik M. Frequencies of the common promoter polymorphisms in MMP1 and MMP3 genes in a Bulgarian population. Sci Technol Med. 2011;1:55–60.
   Google Scholar
• Price SJ, Greaves DR, Watkins H. Identification of novel, functional genetic variants in the human matrix metalloproteinase-2 gene: role of Sp1 in allele-specific transcriptional regulation. J Biol Chem. 2001;276:7549–7558.
   PubMed Web of Science ®Google Scholar
• Yu C, Zhou Y, Miao X, Xiong P, Tan W, Lin D. Functional haplotypes in the promoter of matrix metalloproteinase-2 predict risk of the occurrence and metastasis of esophageal cancer. Cancer Res. 2004;64:7622–7628.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Arriaga P, Pascual T, Garcia-Alvarez A, Fernandez-Somoano A, Lopez-Cima MF, Tardon A. Genetic polymorphisms in MMP 2, 9 and 3 genes modify lung cancer risk and survival. BMC Cancer. 2012;12:1471–2407.
   Web of Science ®Google Scholar
• Karasneh JA, Bani-Hani ME, Alkhateeb AM, Hassan AF, Thornhill MH. Association of MMP but not TIMP-1 gene polymorphisms with recurrent aphthous stomatitis. Oral Dis. 2014;20:693–699.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Gu Z, Qiu G. Association of the polymorphism of MMP2 with the risk and severity of lumbar disc degeneration in the Chinese Han population. Eur Rev Med Pharmacol Sci. 2013;17:1830–1834.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Yu C, Miao X, Wang Y, Tan W, Sun T, Zhang X, Xiong P, Lin D. Functional haplotypes in the promoter of matrix metalloproteinase-2 and lung cancer susceptibility. Carcinogenesis. 2005;26:1117–1121.
   PubMed Web of Science ®Google Scholar